Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-4-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0936-6555
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
352-3
|
pubmed:dateRevised |
2008-3-10
|
pubmed:meshHeading |
pubmed-meshheading:7873479-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7873479-Chemotherapy, Adjuvant,
pubmed-meshheading:7873479-Female,
pubmed-meshheading:7873479-Humans,
pubmed-meshheading:7873479-Premedication,
pubmed-meshheading:7873479-Radiotherapy Dosage,
pubmed-meshheading:7873479-Survival Rate,
pubmed-meshheading:7873479-Treatment Outcome,
pubmed-meshheading:7873479-Uterine Cervical Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
Does neo-adjuvant chemotherapy have a role in cervical cancer?
|
pubmed:publicationType |
Editorial
|